Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience

Publisher： John Wiley & Sons Inc

E-ISSN： 1934-6638|122|7|527-535

ISSN： 1934-662x

Source： CANCER CYTOPATHOLOGY, Vol.122, Iss.7, 2014-07, pp. : 527-535

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quality Control and Telemedicine for BRAF V600E Mutations in Papillary Thyroid Carcinomas: Image Analysis and Classification and Regression Trees

By  

International Journal of Reliable and Quality E-Healthcare (IJRQEH), Vol. 4, Iss. 2, 2015-04 ,pp. : 12-30

IGI Global_journal

Access to resources Recommend Favorite

Clinicopathological and molecular implications of aberrant thyroid transcription factor‐1 expression in colorectal carcinomas: an immunohistochemical analysis of 1319 cases using three different antibody clones

By  

HISTOPATHOLOGY, Vol. 72, Iss. 3, 2018-02 ,pp. : 423-432

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of BRAF molecular analysis in the management of papillary thyroid carcinoma: analysis of cytological and histological samples

By  

CYTOPATHOLOGY, Vol. 956-5507, Iss. 5, 2015-10 ,pp. : 297-302

John Wiley & Sons Inc

Access to resources Recommend Favorite

Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience

By  

CYTOPATHOLOGY, Vol. 956-5507, Iss. 5, 2015-10 ,pp. : 288-296

John Wiley & Sons Inc

Access to resources Recommend Favorite

Afirma GEC and thyroid lesions: An institutional experience

By  

DIAGNOSTIC CYTOPATHOLOGY, Vol. 43, Iss. 12, 2015-12 ,pp. : 966-970

John Wiley & Sons Inc

Access to resources Recommend Favorite